Health stocks decline as Trump nominates RFK Jr for health secretary
bbc.com —
Health stocks fell sharply on Friday after Donald Trump announced Robert F. Kennedy Jr. as his choice for US Health Secretary. Kennedy, known for his skepticism about vaccines, could challenge the pharmaceutical industry if confirmed. Shares of major vaccine makers like Pfizer and Moderna dropped over 5% in early trading. European companies such as AstraZeneca and GSK also saw declines, reflecting investor concerns about Kennedy's potential impact on health policies. Kennedy's nomination represents a shift from the previous administration's approach, which supported vaccine development. His past campaign focused on stricter regulations on food and drug companies, raising uncertainty in the healthcare sector.